孤立性脑转移非小细胞肺癌患者的临床决策探讨  

Clinical decision on solitary brain metastasis in patients with nonsmall cell lung cancer

作　　者：王斌[1] 孟斌[2] 肖渤瀚[3] 宫立群[4] 王晓光[5] 赵路军[6] 潘战宇[1] 

机构地区：[1]天津医科大学肿瘤医院中西医结合科,国家肿瘤临床医学研究中心,天津市肿瘤防治重点实验室,天津市300060 [2]天津医科大学肿瘤医院病理科,天津市300060 [3]天津医科大学肿瘤医院放射科,天津市300060 [4]天津医科大学肿瘤医院肺部肿瘤科,天津市300060 [5]天津医科大学肿瘤医院脑系肿瘤科,天津市300060 [6]天津医科大学肿瘤医院放射治疗科,天津市300060

出　　处：《中国肿瘤临床》2015年第5期302-306,共5页Chinese Journal of Clinical Oncology

摘　　要：既往认为孤立性脑转移非小细胞肺癌(NSCLC)患者属于Ⅳ期,一般不考虑手术治疗,仅给予化疗或放疗等治疗,但很难达到理想的疗效。近年来通过多学科协作体系(MDT)给予规范化、个体化治疗,使患者的获益程度明显增加,甚至可以达到治愈。现介绍2例天津医科大学肿瘤医院多学科协作治疗孤立性脑转移NSCLC患者的病例,以期探讨和制定相应诊疗规范,让更多的患者受益。Solitary brain metastasis in non-small cell lung cancer（NSCLC） patients was previously considered as Stage IV. Generally, only chemotherapy or radiotherapy rather than surgery was considered the treatment for these patients; hence, achieving the desired effect was difficult. In recent years, the treatment benefit for these patients significantly increased. Several patients were even provided the chance of being cured through standardized and individualized treatment by a multiple disciplinary team（MDT）. This article introduces two solitary brain metastasis patients with NSCLC who were treated by MDT in Tianjin Medical University Cancer Institute and Hospital. This article aims to explore a complete set of diagnostic and treatment practices for the benefit of more patients.

关 键 词：孤立性脑转移 非小细胞肺癌 多学科协作 

分 类 号：R734.2[医药卫生—肿瘤]